Straus Family Creamery asked customers to throw out some tubs sold in May across 17 states. No injuries have been reported, the company said.
Category: Food and Drug Administration
-
Rich Danker, RFK Jr.’s Top Spokesman, Resigns in Protest Over New Vaping Policy
In a letter to President Trump, the spokesman, Rich Danker, said allowing the sale of flavored e-cigarettes would enhance their appeal to children.
-
F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure
The agency’s top food official will step in as acting commissioner, after Dr. Makary’s tumultuous run as the nation’s top food, drug, tobacco and medical device regulator.
-
Kennedy Is Driving a Vast Inquiry Into Vaccines, Despite His Public Silence
Health Secretary Robert F. Kennedy Jr. has toned down his public criticism of vaccines, under orders from the White House. But inside his department, a sprawling research effort is a top priority.
-
Trump Plans to Fire F.D.A. Commissioner Marty Makary
Dr. Makary has been a supporter of the Make American Healthy Again Movement but made some enemies in the administration over vaping, the abortion pill and rejections of new drugs.
-
MAHA Awaits Robert F. Kennedy Jr.’s Definition of Ultraprocessed Foods
Some yogurts and peanut butters could be considered ultraprocessed as scientists and MAHA supporters push for a strict definition.
-
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
-
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.
-
‘Under Protest,’ Raw Dairy Farm Recalls Cheddar Linked to 9 E. Coli Cases
Raw Farm, a dairy producer in California, denies that its products have caused the outbreak, which has sickened people in three states.
-
FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes
The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.
